Results 121 to 130 of about 27,055 (203)

Sulfometuron-Methyl Disrupts Early Zebrafish Embryonic Development via Wnt/β-Catenin Signaling Pathway. [PDF]

Toxics
Zhang X, Liu J, Guo Y, Zhong J, Dong Y, Cheng S, Li Z, Qiang W, Wang H.   +8 more
europepmc   +1 more source

KCNJ11-associated infantile epileptic spasms syndrome and neonatal diabetes. [PDF]

Epileptic Disord
Gonzalez BJ, Juanes M, Touzon MS, Alonso C, Obregon Gomez LR, Moreno N, Prieto M, Persico AL, Valenzuela GR, Caraballo R.   +9 more
europepmc   +1 more source

Deconstructing the Master Switch: Advances in Direct NLRP3 Inhibition. [PDF]

Pharmaceuticals (Basel)
Xu Y, Murphy S.
europepmc   +1 more source

Comparative safety of sulfonylurea therapies on cardiovascular and severe hypoglycemia outcomes among adults with type 2 diabetes and moderate cardiovascular risk: a target trial emulation. [PDF]

BMJ Open Diabetes Res Care
Sklepinski S, Ratzki-Leewing AA, Herrin J, Swarna KS, Deng Y, Polley EC, Neumiller JJ, Galindo RJ, Umpierrez GE, Ross JS, Brito JP, Montori VM, Borah BJ, Maron BA, Mickelson MM, McCoy RG.   +15 more
europepmc   +1 more source

Antidiabetic drug and chronic respiratory disease in type 2 diabetes: a network meta-analysis and Mendelian randomization analysis. [PDF]

Ther Adv Endocrinol Metab
Patel I, Chai YH, Wang ZQ, Xu H, Zhang JY, Simo R, Tang XY, Zhou JB.   +7 more
europepmc   +1 more source

Associations of glucose- and lipid-lowering medications with incident or first-recorded psoriasis: a systematic review of real-world observational studies. [PDF]

Front Pharmacol
Li Z, Yang J, Chen D.
europepmc   +1 more source

Causal association between antidiabetic drug targets and risk of Bell's palsy: A 2-sample Mendelian randomization study. [PDF]

Medicine (Baltimore)
Lu K, Ye L, Yi X, He Y.
europepmc   +1 more source

Continuous glucose monitoring-based evaluation of percentage coefficient of variation (%CV) as a metric of intraday glycemic variability in South India. [PDF]

Sci Rep
Hussain MA, Kumar H A, Lingaiah M.
europepmc   +1 more source

Dulaglutide versus empagliflozin as add-on therapy to metformin and sulfonylurea in type 2 diabetes: a randomized pilot study with exploratory metabolomic and microbiome analyses. [PDF]

Front Endocrinol (Lausanne)
Jun JE, Oh DH, Jeong IK, Ryu HJ, Hwang YC, Ahn KJ, Chung HY, Kim KP.   +7 more
europepmc   +1 more source